Clinical Trials

These are all the clinical trials available. Choose a specialty if you want to narrow down the list.

A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)

Type 2 Diabetes Drug Research Study
The assessments for subjects on the once-weekly injection of exenatide (Bydureon) will be compared to a group receiving daily sitagliptin (Januvia) or placebo. (REF# 00042920)

Adult ADHD Medication Study
A nationwide research study of a new investigational drug for adults with ADHD. Duke University Medical Center in Durham, NC, will conduct this study. Study-related evaluations and study drug will be provided at no cost to those who qualify. (REF# 00042466)

Ixmyelocel-T Study
Intramuscular injections of autologous Ixmyelocel-T cells versus placebo for the treatment of patients with peripheral artery disease and critical limb ischemia with no options for revascularization. (REF# Pro00040839)

ROSETTA STUDY
The Rosetta study is comparing two therapies for urge urinary incontinence. The two therapies are Botox®, a medication injected into the bladder versus InterStim® Therapy, a reversible treatment that uses mild electrical pulses to stimulate nerves going to your bladder (neuromodulation) that influence bladder function. (REF# pro00034631)

A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication (IC)
Intramuscular injection of placental (PLX-PAD) cells versus placebo for the treatment of patients with peripheral artery disease and intermittent claudication. (REF# Pro00038962)

EUCLID – Examining Use of Ticagrelor in PAD
Determine the efficacy and safety of oral antiplatelet agents (ticagrelor versus clopidogrel) in patients with symptomatic peripheral artery disease (prior revascularization procedure or ABI < 0.80). (REF# Pro00039981)

Hepatitis C Virus in Pregnancy
Study Goal: to identify risk factors associated with mother to child transmission of HCV (REF# 40221)

CMV in Pregnancy
Study Goal: to determine whether maternal administration of CMV hyperimmune globulin prior to 24 weeks gestation in women diagnosed with primary CMV infection reduces the rate of congenital CMV infection (REF# 34414)

Tadalafil and Gastroparesis
FIXME (REF# 00037289)

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 of 18